208 related articles for article (PubMed ID: 30342273)
1. Unveiling the olfactory proteostatic disarrangement in Parkinson's disease by proteome-wide profiling.
Lachén-Montes M; González-Morales A; Iloro I; Elortza F; Ferrer I; Gveric D; Fernández-Irigoyen J; Santamaría E
Neurobiol Aging; 2019 Jan; 73():123-134. PubMed ID: 30342273
[TBL] [Abstract][Full Text] [Related]
2. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
[TBL] [Abstract][Full Text] [Related]
3. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E
Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091
[TBL] [Abstract][Full Text] [Related]
4. Tackling the Biological Meaning of the Human Olfactory Bulb Dyshomeostatic Proteome across Neurological Disorders: An Integrative Bioinformatic Approach.
Cartas-Cejudo P; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768771
[TBL] [Abstract][Full Text] [Related]
5. Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer's disease progression.
Lachén-Montes M; González-Morales A; Zelaya MV; Pérez-Valderrama E; Ausín K; Ferrer I; Fernández-Irigoyen J; Santamaría E
Sci Rep; 2017 Aug; 7(1):9115. PubMed ID: 28831118
[TBL] [Abstract][Full Text] [Related]
6. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Analysis of the Human Olfactory Bulb.
Dammalli M; Dey G; Madugundu AK; Kumar M; Rodrigues B; Gowda H; Siddaiah BG; Mahadevan A; Shankar SK; Prasad TSK
OMICS; 2017 Aug; 21(8):440-453. PubMed ID: 28816642
[TBL] [Abstract][Full Text] [Related]
8. RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction.
Tremblay C; Aslam S; Walker JE; Lorenzini I; Intorcia AJ; Arce RA; Choudhury P; Adler CH; Shill HA; Driver-Dunckley E; Mehta S; Piras IS; Belden CM; Atri A; Beach TG; Serrano GE
Neurobiol Dis; 2024 Jun; 196():106514. PubMed ID: 38663633
[TBL] [Abstract][Full Text] [Related]
9. Sex-divergent effects on the NAD+-dependent deacetylase sirtuin signaling across the olfactory-entorhinal-amygdaloid axis in Alzheimer's and Parkinson's diseases.
Cartas-Cejudo P; Lachén-Montes M; Ferrer I; Fernández-Irigoyen J; Santamaría E
Biol Sex Differ; 2023 Feb; 14(1):5. PubMed ID: 36755296
[TBL] [Abstract][Full Text] [Related]
10. A ventral glomerular deficit in Parkinson's disease revealed by whole olfactory bulb reconstruction.
Zapiec B; Dieriks BV; Tan S; Faull RLM; Mombaerts P; Curtis MA
Brain; 2017 Oct; 140(10):2722-2736. PubMed ID: 28969383
[TBL] [Abstract][Full Text] [Related]
11. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
Beach TG; White CL; Hladik CL; Sabbagh MN; Connor DJ; Shill HA; Sue LI; Sasse J; Bachalakuri J; Henry-Watson J; Akiyama H; Adler CH;
Acta Neuropathol; 2009 Feb; 117(2):169-74. PubMed ID: 18982334
[TBL] [Abstract][Full Text] [Related]
12. Amyotrophic Lateral Sclerosis Is Accompanied by Protein Derangements in the Olfactory Bulb-Tract Axis.
Lachén-Montes M; Mendizuri N; Ausin K; Andrés-Benito P; Ferrer I; Fernández-Irigoyen J; Santamaría E
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167591
[TBL] [Abstract][Full Text] [Related]
13. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.
Mundiñano IC; Caballero MC; Ordóñez C; Hernandez M; DiCaudo C; Marcilla I; Erro ME; Tuñon MT; Luquin MR
Acta Neuropathol; 2011 Jul; 122(1):61-74. PubMed ID: 21553300
[TBL] [Abstract][Full Text] [Related]
14. Olfactory Bulb Proteomics Reveals Widespread Proteostatic Disturbances in Mixed Dementia and Guides for Potential Serum Biomarkers to Discriminate Alzheimer Disease and Mixed Dementia Phenotypes.
Lachén-Montes M; Íñigo-Marco I; Cartas-Cejudo P; Fernández-Irigoyen J; Santamaría E
J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34204996
[TBL] [Abstract][Full Text] [Related]
15. Neocortical Lewy bodies are associated with impaired odor identification in community-dwelling elders without clinical PD.
Nag S; Yu L; VanderHorst VG; Schneider JA; Bennett DA; Buchman AS; Wilson RS
J Neurol; 2019 Dec; 266(12):3108-3118. PubMed ID: 31535271
[TBL] [Abstract][Full Text] [Related]
16. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.
Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
Acta Neuropathol; 2010 Jun; 119(6):723-35. PubMed ID: 20383714
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease and alpha-synuclein pathology in the olfactory bulbs of infants, children, teens and adults ≤ 40 years in Metropolitan Mexico City. APOE4 carriers at higher risk of suicide accelerate their olfactory bulb pathology.
Calderón-Garcidueñas L; González-Maciel A; Reynoso-Robles R; Kulesza RJ; Mukherjee PS; Torres-Jardón R; Rönkkö T; Doty RL
Environ Res; 2018 Oct; 166():348-362. PubMed ID: 29935448
[TBL] [Abstract][Full Text] [Related]
18. The olfactory bulb proteotype differs across frontotemporal dementia spectrum.
Lachén-Montes M; González-Morales A; Schvartz D; Zelaya MV; Ausin K; Fernández-Irigoyen J; Sánchez JC; Santamaría E
J Proteomics; 2019 Jun; 201():37-47. PubMed ID: 30999060
[TBL] [Abstract][Full Text] [Related]
19. Secretagogin-containing neurons in the mouse main olfactory bulb.
Kosaka K; Kosaka T
Neurosci Res; 2013; 77(1-2):16-32. PubMed ID: 24008127
[TBL] [Abstract][Full Text] [Related]
20. Secretagogin expression in the mouse olfactory bulb under sensory impairments.
Pérez-Revuelta L; Téllez de Meneses PG; López M; Briñón JG; Weruaga E; Díaz D; Alonso JR
Sci Rep; 2020 Dec; 10(1):21533. PubMed ID: 33299042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
